Phase II study of axitinib intensification compared to nivolumab alone after induction with ipilimumab plus nivolumab in patients with mRCC without previous complete response (AxIn study).Chiara Ciccarese, Roberto Iacovelli, Davide Bimbatti et al.|Journal of Clinical Oncology|2024Cited by 0